2003
DOI: 10.1021/ci034078l
|View full text |Cite
|
Sign up to set email alerts
|

Predicting Biotransformation Potential from Molecular Structure

Abstract: The program PASS-BioTransfo is presented, which is capable of predicting many classes of biotransformation for chemical compounds. A particular class of biotransformation is defined by the chemical transformation type and may additionally include the name of the enzyme involved in a transformation. An evaluation of the approach is presented, using biotransformations taken from the databases Metabolite (MDL) and Metabolism (Accelrys), respectively. When trained with biotransformations from Metabolite, PASS-BioT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(12 citation statements)
references
References 17 publications
0
12
0
Order By: Relevance
“…It is true that coupling was also efficient in the oxidation of o-xylene by variant RLYF/A330P (62 %), where no single product accounted for more than 30 % of the total, but this was because the constricted A330P active site [26] suits compact substrates, [18] while the RLYF couplet may reduce peroxide formation by mitigating active-site water levels. [8] Computational studies predicted dearomatisation as an oxidation pathway for CYP1A1, [46] but to the best of our knowledge it has not previously been reported as an experimental outcome. Relatively few substrates possess structures that render them susceptible to such rearrangements, but ortho-substituted aromatics are evidently potential candidates when oxidised by isoforms that allow limited substrate mobility.…”
Section: Discussionmentioning
confidence: 87%
“…It is true that coupling was also efficient in the oxidation of o-xylene by variant RLYF/A330P (62 %), where no single product accounted for more than 30 % of the total, but this was because the constricted A330P active site [26] suits compact substrates, [18] while the RLYF couplet may reduce peroxide formation by mitigating active-site water levels. [8] Computational studies predicted dearomatisation as an oxidation pathway for CYP1A1, [46] but to the best of our knowledge it has not previously been reported as an experimental outcome. Relatively few substrates possess structures that render them susceptible to such rearrangements, but ortho-substituted aromatics are evidently potential candidates when oxidised by isoforms that allow limited substrate mobility.…”
Section: Discussionmentioning
confidence: 87%
“…One particular limitation of the programs is that they do not provide a comprehensive list of all theoretically possible biotransformation reactions for the drug. Computer‐based systems for the prediction of routes of drug metabolism are available and are becoming more reliable as metabolism data for different compounds is added to them but it is still not possible to fully predict the metabolism of a particular compound solely on the basis of its structure 12…”
mentioning
confidence: 99%
“…It was intended to be a wide collection of metabolism data with a focus on quantity rather than quality [23] and now includes compounds from New Drug Applications, proceedings from meetings of the International Society for the Study of Xenobiotics and the scientific literature from 1990 onward [11]. These are mainly pharmaceutical compounds, but also include food additives, industrial chemicals and agrochemicals [28]. The latest version at the time of writing, 2011.2, contains 62,465 molecules and 103,907 biotransformation reactions, of which 36,041 are in humans.…”
Section: Effects Of Metabolism On Compound Structuresmentioning
confidence: 99%